Sort
326,823 grants matching “clinical trial”
ACTIV Integration of Host-targeting Therapies for COVID-19 Administrative Coordinating Center
$169,000,000Sonia M Thomas · Research Triangle Institute · OT2 · FY2020 · HL
National Biocontainment Laboratory (NBL)
$110,090,673University Of Texas Medical Br Galveston · UC6 · FY2003 · AI
Completion of ACTIV-2 Study
$82,531,927Angee Greer · Ppd Development Lp · N01 · FY2022 · AI
Antiviral Program for Pandemics (APP) & NCATS: Accelerating Antiviral Development
$77,500,000Matthew Hall · National Center For Advancing Translational Sciences · ZIA · FY2022 · TR
ACTIV-6
$77,049,200Daniel K Benjamin · Duke University · U24 · FY2021 · TR
AIDS Clinical Trials Group for Research on Therapeutics for HIV and Related Infections
$76,222,582Judith S. Currier · University Of California Los Angeles · UM1 · FY2023 · AI
TAS::75 0849::TAS INCREMENTAL FUNDING
$72,678,963David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2012 · CA
COVID-19: NIAID Clinical Research Support Services (CRSS)
$72,422,544Bambra Strokes · Ppd Development Lp · N01 · FY2020 · AI
Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/
$71,500,000Judith S. Currier · University Of California Los Angeles · UM1 · FY2022 · AI
HIV Prevention Trials Network Leadership and Operations Center
$70,307,771Myron S Cohen · Family Health International · UM1 · FY2021 · AI
ACTIV Integration of Host-targeting Therapies for COVID-19 Administrative Coordinating Center
$68,177,802Tracy L Nolen · Research Triangle Institute · OT2 · FY2020 · HL
AI-driven Structure-enabled Antiviral Platform (ASAP)
$67,673,902John Damon Chodera · Sloan-Kettering Inst Can Research · U19 · FY2022 · AI
Center for Antiviral Medicines & Pandemic Preparedness (CAMPP)
$67,624,156Sumit K Chanda · Scripps Research Institute, The · U19 · FY2022 · AI
ON BEHALF OF NIAID-DCR, FACILITATE THE CONDUCT OF TWO, RANDOMIZED TRIALS AS DETAILED BELOW IN I AND II:I. A RANDOMIZED BLINDED CONTROLLED TRIAL OF TH
$67,359,812Beth Baseler · Leidos Biomedical Research, Inc. · N01 · FY2020 · CA
INFECTIOUS DISEASE, VACCINE, CLINICAL TRIALS AND ENTOMOLOGY AWARD (IDVCTEA)
$67,205,571Kenya Medical Research Institute · · FY2013 · Defense Health Agency
Establishment and operation of a Vaccine Pilot Plant
$66,352,968Jason Gall · National Institute Of Allergy And Infectious Diseases · ZIB · FY2024 · AI
Establishment and operation of a Vaccine Pilot Plant
$66,062,291Jason Gall · National Institute Of Allergy And Infectious Diseases · ZIB · FY2023 · AI
Division of Cancer Tratment and DIagnosis- Operational Task Order
$63,381,339Leonard Freedman · Leidos Biomedical Research, Inc. · N01 · FY2020 · CA
Division of Cancer Treatment and Diagnosis- Operational Task Order
$62,828,083Leonard Freedman · Leidos Biomedical Research, Inc. · N01 · FY2021 · CA
CoVPN 3005 - Efficacy, Immunogenicity, and Safety of SARS-CoV-2 Recombinant Protein Vaccine with Adjuvant in Adults 18 Years of Age and Older
$61,429,109Lawrence Corey · Fred Hutchinson Cancer Research Center · UM1 · FY2021 · AI
Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/
$60,609,395Daniel R Kuritzkes · Brigham And Women'S Hospital · UM1 · FY2018 · AI
Integrated Research Facility at Fort Detrick
$58,051,257Connie Schmaljohn · National Institute Of Allergy And Infectious Diseases · ZIC · FY2024 · AI
Division of Cancer Treatment and Diagnosis- Operational Task Order
$57,674,955Leonard Freedman · Leidos Biomedical Research, Inc. · N01 · FY2022 · CA
Molecular characterization and clinical assay development program
$57,230,985Mickey Williams · Leidos Biomedical Research, Inc. · N01 · FY2016 · CA
Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/
$56,989,695Daniel R Kuritzkes · Brigham And Women'S Hospital · UM1 · FY2017 · AI